magnifying glass
logo for Kolon TissueGene

Kolon TissueGene

Get Full Access

Description

Kolon TissueGene, Inc., is an advanced cell therapies company that has developed a first-in-class cell and gene therapy targeting OA of the knee. Kolon TissueGe... Read More

Headquarters

Headquarters:

9713 Ave, Key West Ste 300, Rockville, Maryland, 20850, United States
Phone

Phone:

(301) 921-6000
Employees

Employees:

39
Revenue

Revenue:

$7 Million
Kolon TissueGene's Social Media
SIC Code 28,283
NAICS Code 32541,325
Popular Searches:

tissuegene , inc.

Kolon TissueGene Inc

TissueGene Inc

Kolon TissueGene

TissueGene, Inc.

Top Competitors of Kolon TissueGene

Employess
<25
revenue
<$5 Million

1

Employess
39
revenue
$7 Million

2

Employess
<25
revenue
$6 Million

3

Employess
83
revenue
$5 Million

4

Employess
33
revenue
$6 Million

5

Employess
33
revenue
<$5 Million

6

Kolon TissueGene's Org Chart

Lee Woosok
Lee Woosok

President & Chief Executive Officer

PhonePhoneEmailEmail
Soon-Wook Kweon
Soon-Wook Kweon

Chief Financial Officer

PhonePhoneEmailEmail

PhonePhoneEmailEmail

PhonePhoneEmailEmail

PhonePhoneEmailEmail
Illustration of an envelope

Kolon TissueGene Company Metrics

Company Insights
Employee Growth Rate
Revenue
QuarterRevenue

'20 - Q3

9336000

'20 - Q4

9336000

'21 - Q1

8078000

'21 - Q2

8078000

Kolon TissueGene's Tech Stack

Google Analytics

By

Google

AppRiver

By

AppRiver

reCAPTCHA

By

Google

Office 365

By

Microsoft

Google Universal Analytics

By

Google

Google Font API

By

Google
See more technologies

Kolon TissueGene News & Media

KOLON TISSUEGENE RESUMES TG-C PHASE III STUDIES IN THE U.S.

ROCKVILLE, Md., Dec. 28, 2021 /PRNewswire/ -- Kolon TissueGene, Inc. (KOSDAQ: 950160) (the "Company"), a leader in advanced cell and gene therapies, announced today that it has resumed patient dosing in its U.S. Phase III study of TG-C for the treatment of knee osteoarthritis (OA). The...

Kolon TissueGene To Expand Indications For TG-C

ROCKVILLE, Md., Dec. 3, 2021 /PRNewswire/ -- Kolon TissueGene, Inc. ("the Company"), a leader in advanced cell and gene therapies, announced today that the FDA has allowed the Company to proceed with initiation of a Phase II clinical trial in osteoarthritis (OA) of the hip. Kolon...

Advanced Cell Therapies Market Projected to Show Strong Growth : Fujifilm, Vericel, Kolon TissueGene, Gamida Cell

Edison, NJ -- (SBWIRE) -- 07/13/2020 -- A new market study is released on Covid-19 Impact on Global Advanced Cell Therapies Market with data Tables for historical and forecast years represented with Chats &amp; Graphs spread through 90 Pages with easy to understand detailed analysis. The study highlights detailed assessment of the Market and display market sizing trend by revenue &amp; volume (if applicable), current growth factors, expert opinions, facts, and industry validated market developme
Subscribe to "Kolon TissueGene" News

Frequently Asked Questions regarding Kolon TissueGene

Where are Kolon TissueGene’s headquarters?

Kolon TissueGene’s headquarters are in 9713 Ave, Key West Ste 300, Rockville, Maryland, 20850, United States

What is Kolon TissueGene’s phone number?

Kolon TissueGene’s phone number is (301) 921-6000

What is Kolon TissueGene’s official website?

Kolon TissueGene’s official website is //www.tissuegene.com

What is Kolon TissueGene’s Revenue?

Kolon TissueGene’s revenue is $7 Million

What is Kolon TissueGene’s SIC code?

Kolon TissueGene’s SIC: 28,283

What is Kolon TissueGene’s NAICS code?

Kolon TissueGene’s NAICS: 32541,325

How many employees are working in Kolon TissueGene?

Kolon TissueGene has 39 employees

What is Kolon TissueGene’s industry?

Kolon TissueGene is in the industry of: Biotechnology, Pharmaceuticals, Healthcare

Who are Kolon TissueGene’s main competitors?

Kolon TissueGene's main competitors are: Juventas Therapeutics, SanBio, Athira Pharma, Athersys

What is Kolon TissueGene's tech stack?

The technologies that are used by Kolon TissueGene are: Google Analytics, AppRiver, reCAPTCHA, Office 365

Who is Kolon TissueGene's CEO?

Kolon TissueGene's CEO is Woosok Lee

Who is Kolon TissueGene's CFO?

Kolon TissueGene's CFO is Soon-Wook Kweon

See more information about Kolon TissueGene

Browse ZoomInfo’s Directories